hbio2016.hbio.info
Handbook of Personalized Medicine: Advances in Nanotechnology, Drug Delivery, and Therapy: 9789814411196: Medicine & Health Science Books @ Amazon.com
Future Pharmacology | Free Full-Text | Unraveling Drug Response from Pharmacogenomic Data to Advance Systems Pharmacology Decisions in Tumor Therapeutics
Konstantinos LIARAS | Adjunct Faculty | Pharmacist, MSc, PhD | University of Nicosia, Nicosia | Department of Life & Health Sciences | Research profile
Loop | Ioannis S Vizirianakis
Ioannis Vizirianakis | Aristotle University of Thessaloniki - Academia.edu
Ioannis Vizirianakis - Associate Professor - Aristotle University of Thessaloniki | LinkedIn
Our Team | MetaThess - iGEM 2022
Generation of Chemobrionic Jellyfish‐Like Structures That Mechanically Divide and Exhibit Biomimetic “Symbiosis” - Angelis - 2022 - ChemSystemsChem - Wiley Online Library
Vizirianakis Ioannis | PMS Toxicology
Ioannis VIZIRIANAKIS | Professor (Associate) | PhD | Aristotle University of Thessaloniki, Thessaloníki | AUTH | Laboratory of Pharmacology School of Pharmacy | Research profile
Ioannis Vizirianakis on LinkedIn: Αριστεία Φαρμακευτικής Αγοράς: Βραβεύτηκε με την τιμητική διάκριση… | 18 comments
Gold medal in the team of AUTh "iGEM Thessaloniki" - Study in Greece
Pharmacy (MPharm, Integrated Master, 5 Years) – University of Nicosia
Development of a novel PTD-mediated IVT-mRNA delivery platform for potential protein replacement therapy of
Awards – Functional Proteomics and Systems Biology Research Group
Team:Thessaloniki/Team - 2021.igem.org
Future Pharmacology | Free Full-Text | Systems Pharmacology and Network Analysis to Advance Pharmacogenomics and Precision Medicine Decisions in Type-2 Diabetes Therapy
International award for the Scientific Team of AUTh - Study in Greece
Enabling personalized cancer medicine decisions: The challenging pharmacological approach of PBPK models for nanomedicine and p
Panagiotis Zagaliotis, PhD | Ndhlovulab
Boron-containing delocalised lipophilic cations for the selective targeting of cancer cells
Pharmaceuticals MDPI on Twitter: "Dr. Ioannis S. Vizirianakis et al. proofed miR-16-5p is a differentiation-promoting agent in #erythroleukemia cells, which can promote erythroid maturation of erythroleukemia cells by regulating #ribosome biogenesis ...
